Larimar Therapeutics Inc (LRMR) Event Oct. 20, 2022, 12:11 UTC 27 1 comments (85% Positive) Larimar Therapeutics, Inc. (LRMR) Announces Enrollment Update for objectives Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Talaris Therapeutics Inc (TALS) Event Oct. 20, 2022, 11:12 UTC 28 1 comments (80% Positive) TALARIS THERAPEUTICS, INC. (TALS) Announces Enrollment Update for study Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment Comment Full text
Axsome Therapeutics Inc (AXSM) Event Oct. 20, 2022, 11:05 UTC 30 1 comments (90% Positive) Axsome Therapeutics, Inc. (AXSM) Announces Enrollment Update for approved Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Alkermes plc (ALKS) Event Oct. 19, 2022, 20:45 UTC 27 1 comments (99% Neutral) Alkermes plc. (ALKS) Announces Business Combination Comment Full text
Fulcrum Therapeutics (FULC) Event Oct. 19, 2022, 20:06 UTC 26 1 comments (99% Neutral) FULCRUM THERAPEUTICS, INC. (FULC) Announces Executive Departure Comment Full text
Arcus Biosciences Inc. (RCUS) Event Oct. 19, 2022, 14:00 UTC 102 0 comments Arcus Biosciences - Arcus Biosciences Third Quarter 2022 Results (Release Only) Comment Full text
RedHill Biopharma (RDHL) Event Oct. 19, 2022, 11:04 UTC 19 1 comments (80% Positive) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Comment Full text
KAMADA (KMDA) Event Oct. 19, 2022, 11:00 UTC 21 1 comments (10% Negative) KAMADA (KMDA) Announces Regulatory Update (Form 6-K) Comment Full text
Jazz Pharmaceuticals plc (JAZZ) Event Oct. 19, 2022, 10:59 UTC 26 1 comments (10% Negative) Jazz Pharmaceuticals plc (JAZZ) Announces Business Combination Comment Full text
Insmed Inc (INSM) Event Oct. 19, 2022, 10:13 UTC 29 1 comments (10% Negative) INSMED INCORPORATED (INSM) Reports Q4 2022 Financial Results Comment Full text